JP2021523915A5 - - Google Patents
Info
- Publication number
- JP2021523915A5 JP2021523915A5 JP2020564201A JP2020564201A JP2021523915A5 JP 2021523915 A5 JP2021523915 A5 JP 2021523915A5 JP 2020564201 A JP2020564201 A JP 2020564201A JP 2020564201 A JP2020564201 A JP 2020564201A JP 2021523915 A5 JP2021523915 A5 JP 2021523915A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- compound represented
- structural formula
- haloalkyl
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862671833P | 2018-05-15 | 2018-05-15 | |
| US62/671,833 | 2018-05-15 | ||
| PCT/US2019/032476 WO2019222392A1 (en) | 2018-05-15 | 2019-05-15 | Compounds for treatment of pancreatic cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021523915A JP2021523915A (ja) | 2021-09-09 |
| JP2021523915A5 true JP2021523915A5 (cg-RX-API-DMAC7.html) | 2022-03-03 |
Family
ID=68541005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020564201A Pending JP2021523915A (ja) | 2018-05-15 | 2019-05-15 | 膵臓癌の治療のための化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20190374512A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3793548A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2021523915A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20210021982A (cg-RX-API-DMAC7.html) |
| CN (1) | CN112437664A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2019270091A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3099922A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2020012292A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019222392A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL293661B2 (en) * | 2020-04-03 | 2025-11-01 | Veru Inc | Sabizabulin for treating coronavirus infection |
| MX2023011719A (es) * | 2021-04-05 | 2023-11-09 | Veru Inc | Métodos de tratamiento de la inflamación. |
| IL316387A (en) * | 2022-04-28 | 2024-12-01 | Veru Inc | Polymorphs of [2-(1H-INDOL-3-YL)-1H-IMIDAZOL-4-YL](3,4,5-TRIMETHOXYPHENYL)methanone and its salts |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8822513B2 (en) * | 2010-03-01 | 2014-09-02 | Gtx, Inc. | Compounds for treatment of cancer |
| US9447049B2 (en) * | 2010-03-01 | 2016-09-20 | University Of Tennessee Research Foundation | Compounds for treatment of cancer |
| UA105005C2 (uk) * | 2008-06-16 | 2014-04-10 | Юніверсіті Оф Теннессі Рісерч Фаундейшн | Сполуки для лікування раку |
| US9029408B2 (en) * | 2008-06-16 | 2015-05-12 | Gtx, Inc. | Compounds for treatment of cancer |
| CA2791738C (en) * | 2010-03-01 | 2020-06-09 | Gtx, Inc. | Aryl imidazolyl compounds for the treatment of cancer |
| MX336761B (es) * | 2010-08-24 | 2016-01-29 | Univ Tennessee Res Foundation | Compuestos para el tratamiento de cancer. |
| CN105163584B (zh) * | 2013-03-05 | 2019-06-04 | 田纳西大学研究基金会 | 用于治疗癌症的化合物 |
-
2019
- 2019-05-15 MX MX2020012292A patent/MX2020012292A/es unknown
- 2019-05-15 CA CA3099922A patent/CA3099922A1/en active Pending
- 2019-05-15 EP EP19802725.2A patent/EP3793548A4/en not_active Withdrawn
- 2019-05-15 JP JP2020564201A patent/JP2021523915A/ja active Pending
- 2019-05-15 KR KR1020207035812A patent/KR20210021982A/ko not_active Withdrawn
- 2019-05-15 CN CN201980046672.7A patent/CN112437664A/zh active Pending
- 2019-05-15 WO PCT/US2019/032476 patent/WO2019222392A1/en not_active Ceased
- 2019-05-15 US US16/413,222 patent/US20190374512A1/en not_active Abandoned
- 2019-05-15 AU AU2019270091A patent/AU2019270091A1/en not_active Abandoned